At a glance

ClinicalIndex Comparison Record

Phase 3Completed· 40 enrolled

Drug / intervention

Toothpaste Tablet +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05805865

NCT05805865Phase 3Completed

Compare CT.gov

Efficacy of Eco-Friendly Toothpaste Tablets Versus Conventional Toothpaste Using PI and GI Index

Loma Linda University·interventional·Posted Apr 10, 2023·Updated Feb 21, 2025

In Brief

A Phase 3 clinical trial evaluating Toothpaste Tablet and Conventional Toothpaste for Gingival Inflammation. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Objectives: To assess the change in gingival index (GI) and plaque index (PI) when comparing the use of toothpaste tablets to conventional toothpaste. Methods: 40 participants were randomized into two groups: Colgate's toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (C). Both groups utilized their assigned dentifrice for 2 weeks. A pre and post-assessment measured the GI and PI index. A questionnaire on the use of the product was distributed.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsGingival Inflammation

CountriesUnited States

Collaborators--

Timeline

Phase 3CompletedFinished

2023202420252026

Enrollment StartJan 2023

Primary CompletionJan 2023

First PostedApr 2023

TodayJul 2026

First PostedApr 10, 2023

Enrollment StartJan 3, 2023

Primary CompletionJan 23, 2023

TodayJul 2, 2026

Enrollment to primary: 20 daysPosted 3.2 years ago

Interventions

Toothpaste Tabletdrug

Colgate Anywhere Toothpaste Tablets

Conventional Toothpastedrug

Colgate Cavity Protection